Neupulse
Neupulse is the brand of Neurotherapeutics Ltd The direction of our current research was very much shaped by the feedback we received from individuals with tic disorders and their families. When we asked them for their thoughts on our research priorities we were frequently told that what was really needed was a safe and effective non-drug treatment for tic disorder that could be used outside of the clinic and gave individuals control over their tics. This led directly to us focusing on the use of peripheral nerve stimulation as a means of bringing about changes in the brain networks associated with the production of tics. We demonstrated that delivering rhythmic patterns of mild electrical stimulation to the median nerve at the wrist could be used to increase the power and the synchronicity of the brain oscillations (rhythms) associated with the suppression of movements, and that this type of stimulation was sufficient to dramatically reduce the frequency of tics and remove the urge-to-tic in individuals with tic disorders. Importantly, we also showed that this type of stimulation did not materially affect the execution of volitional (intentional) movements or impair cognitive functions such as attention.
Domain
neupulse.co.uk
Country
United KingdomIndustry
Health CareEmployees
11-50
Last Funding
$4.1M
Founded
2021
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Neupulse use?+
We have not yet detected technologies for Neupulse.
What industry is Neupulse in?+
Neupulse operates in the Health Care industry.
Where is Neupulse based?+
Neupulse is headquartered in United Kingdom.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026